Siddhartha Kadia bought $800K of Mesa Laboratories (MLAB)
Executed Aug 13, disclosed Aug 17, 4 days later.
Over the 21 trading sessions from the disclosed entry session (Aug 17), the stock returned +21.2% (delay-adjusted); from the execution session (Aug 13), +7.9%. Derived: entry at the session's open, exit at the close 20 sessions later.
Siddhartha Kadia (President and CEO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Mesa Laboratories, Inc. (MLAB). Across 1 priced purchase filing, the average 21-session return was +7.9% from execution and +21.2% from disclosure (delay-adjusted; derived). The largest single filing was $800K of MLAB (7,093 sh × $112.80, as filed), executed Aug 13.
Technology · Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services…
More Technology filings→ Insider filings, newest first→ View the original filing at www.sec.gov→